Daymark Wealth Partners’s GSK GSK Stock Holding History

Daymark Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$500K	Buy	9,051 +969	+12%	+$52.5K	0.02%	424
2025 Q4	$396K	Buy	8,082 +1,312	+19%	+$61.2K	0.01%	443
2025 Q3	$292K	Buy	6,770 +1,044	+18%	+$40.8K	0.01%	484
2025 Q2	$220K	Sell	5,726 -1,338	-19%	-$51.1K	0.01%	522
2025 Q1	$274K	Sell	7,064 -4,206	-37%	-$154K	0.01%	434
2024 Q4	$381K	Sell	11,270 -11,070	-50%	-$399K	0.02%	369
2024 Q3	$913K	Sell	22,340 -3,335	-13%	-$136K	0.04%	256
2024 Q2	$988K	Buy	+25,675	New	+$1.08M	0.05%	239

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Daymark Wealth Partners's GSK Position: Q1 2026 in Review

Daymark Wealth Partners increased its GSK (GSK) stake by 12% in Q1 2026, buying an estimated $52.5K and bringing the position to 9,051 shares worth $500K. The position accounts for 0.02% of the portfolio, ranked #424.

Daymark Wealth Partners first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. The position peaked at $988K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Daymark Wealth Partners held 9,051 shares of GSK worth $500K as of Q1 2026.
Daymark Wealth Partners bought 969 GSK shares in Q1 2026, an estimated $52.5K.
GSK made up 0.02% of Daymark Wealth Partners's portfolio in Q1 2026, its #424 holding.
Daymark Wealth Partners first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
Daymark Wealth Partners's GSK position peaked at $988K in Q2 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.